Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;27(6):334-344.
doi: 10.1136/bmjebm-2021-111825. Epub 2022 Jan 27.

Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review

Julian Hirt  1   2 , Perrine Janiaud  3 , Lars G Hemkens  1   4   5
Affiliations

Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review

Julian Hirt et al. BMJ Evid Based Med. 2022 Dec.

Abstract

Objective: We aimed at providing a systematic overview of randomised trials assessing non-pharmaceutical interventions (NPIs) to prevent COVID-19.

Design: Scoping review.

Methods: We included all randomised trials assessing NPIs to prevent COVID-19 in any country and setting registered in ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform using the COVID-evidence platform (until 17 August 2021). We searched for corresponding publications in MEDLINE/PubMed, Google Scholar, the Living Overview of Evidence platform, and the Cochrane COVID-19 registry as well as for results posted in registries (until 14 November 2021). Descriptive statistics using numbers and percentages were used in the narrative synthesis of the results.

Results: We identified 41 randomised trials. Of them, 12 were completed (29.3%) including 9 with published results. The 41 trials planned to recruit a median of 1700 participants (IQR 588-9500, range 30-35 256 399) with a median planned duration of 8 months (IQR 3-14, range 1-24). Most came from the USA (n=11, 26.8%). The trials mostly assessed protective equipment (n=11, 26.8%), COVID-19-related information and education programmes (n=9, 22.0%), access to mass events under specific safety measures (n=5, 12.2%), testing and screening strategies (n=5, 12.2%) and hygiene management (n=5, 12.2%).

Conclusions: Worldwide, 41 randomised trials assessing NPIs have been initiated with published results available to inform policy decisions for only 9 of them. A long-term research agenda including behavioural, environmental, social and systems level interventions is urgently needed to guide policies and practices in the current and future public health emergencies.

Keywords: global health; infectious diseases; public health.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Retrieval and trial selection process. Abbreviations: ICTRP, International Clinical Trials Registry Platform; NPI, non-pharmaceutical interventions.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organization . Who coronavirus (COVID-19) Dashboard, 2021. Available: https://covid19.who.int/ [Accessed 05 Nov 2021].
    1. World Health Organization . Overview of public health and social measures in the context of COVID-19: interim guidance, 2020. Available: https://www.who.int/publications/i/item/overview-of-public-health-and-so... [Accessed 25 Jul 2021].
    1. Doroshenko A. The combined effect of vaccination and Nonpharmaceutical public health Interventions—Ending the COVID-19 pandemic. JAMA Netw Open 2021;4:e2111675. 10.1001/jamanetworkopen.2021.11675 - DOI - PubMed
    1. Who coronavirus (COVID-19) Dashboard: measures, 2021. Available: https://covid19.who.int/measures [Accessed 17 Nov 2021].
    1. Fretheim A, Flatø M, Steens A, et al. . COVID-19: we need randomised trials of school closures. J Epidemiol Community Health 2020;74:1078–9. 10.1136/jech-2020-214262 - DOI - PubMed

Publication types